EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating Chemerin Is Elevated in Women With Preeclampsia

Lucy A Bartho iD, Manju Kandel, Susan P Walker, Catherine A Cluver, Roxanne Hastie, Lina Bergman, Natasha Pritchard, Ping Cannon, Tuong-Vi Nguyen, Georgia P Wong, Teresa M MacDonald, Emerson Keenan und 3 weitere

Endocrinology · 2023

DOI: 10.1210/endocr/bqad041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2023. Verfasst von Lucy A Bartho und 14 weiteren Autor:innen. Beteiligte Einrichtung: Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, Victoria…. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Swedish Foundation for International Cooperation in Research and Higher Education, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preeclampsia is a severe complication of pregnancy. Chemerin is an adipokine secreted from adipose tissue and highly expressed in placenta. This study evaluated the biomarker potential of circulating chemerin to predict preeclampsia.

Methods

Maternal plasma and placenta were collected from women with early-onset preeclampsia (<34 weeks), with preeclampsia and eclampsia, or before preeclampsia diagnosis (36 weeks). Human trophoblast stem cells were differentiated into syncytiotrophoblast or extravillous trophoblasts across 96 hours. Cells were cultured in 1% O2 (hypoxia) or 5% O2 (normoxia). Chemerin was measured by enzyme-linked immunosorbent assay (ELISA) and RARRES2 (gene coding chemerin) by reverse transcription-quantitative polymerase chain reaction.

Results

Circulating chemerin was increased in 46 women with early-onset preeclampsia (<34 weeks) compared to 17 controls (P < .0006). Chemerin was increased in placenta from 43 women with early-onset preeclampsia compared to 24 controls (P < .0001). RARRES2 was reduced in placenta from 43 women with early-onset preeclampsia vs 24 controls (P < .0001). Chemerin was increased in plasma from 26 women with established preeclampsia (P = .006), vs 15 controls. Circulating chemerin was increased in 23 women who later developed preeclampsia vs 182 who did not (P = 3.23 × 10−6). RARRES2 was reduced in syncytiotrophoblast (P = .005) or extravillous trophoblasts (P < .0001). Hypoxia increased RARRES2 expression in syncytiotrophoblast (P = .01) but not cytotrophoblast cells.

Conclusions

Circulating chemerin was elevated in women with early-onset preeclampsia, established preeclampsia, and preceding preeclampsia diagnosis of preeclampsia. RARRES2 was dysregulated in placenta complicated by preeclampsia and may be regulated through hypoxia. Chemerin may have potential as a biomarker for preeclampsia but would need to be combined with other biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaFemaleHumansPregnancyBiomarkersHypoxiaPlacentaTrophoblastsChemokines

Stichwörter der Autor:innen

adipokinebiomarkerchemerinhypoxiaplacentapreeclampsia

Substanzen

BiomarkersRARRES2 protein, humanChemokines

Autor:innen und Institutionen

  • Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, Victoria 3084, Australia.
  • Mercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria 3084, Australia.
  • Department of Obstetrics and Gynecology, Stellenbosch University, Cape Town 7505, South Africa.
  • Department of Women's and Children's Health, Uppsala University, Uppsala 751 85, Sweden.
  • Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg 405 30, Sweden.

ORCID-Profile: Lucy A Bartho

Förderung

  • National Health and Medical Research Council
  • Swedish Foundation for International Cooperation in Research and Higher Education
  • Swedish Research Council
  • Center for Clinical Research Dalarna

Zitieren

APA

Bartho, L. A., Kandel, M., Walker, S. P., Cluver, C. A., Hastie, R., Bergman, L., Pritchard, N., Cannon, P., Nguyen, T. V., Wong, G. P., MacDonald, T. M., Keenan, E., Hannan, N. J., Tong, S., & Kaitu'u-Lino, T. J. (2023). Circulating Chemerin Is Elevated in Women With Preeclampsia. Endocrinology. https://doi.org/10.1210/endocr/bqad041

Vancouver

Bartho LA, Kandel M, Walker SP, Cluver CA, Hastie R, Bergman L, et al. Circulating Chemerin Is Elevated in Women With Preeclampsia. Endocrinology. 2023. doi:10.1210/endocr/bqad041

BibTeX
@article{Bartho2023,
  author = {Bartho, Lucy A and Kandel, Manju and Walker, Susan P and Cluver, Catherine A and Hastie, Roxanne and Bergman, Lina and Pritchard, Natasha and Cannon, Ping and Nguyen, Tuong-Vi and Wong, Georgia P and MacDonald, Teresa M and Keenan, Emerson and Hannan, Natalie J and Tong, Stephen and Kaitu'u-Lino, Tu'uhevaha J},
  title = {Circulating Chemerin Is Elevated in Women With Preeclampsia},
  journal = {Endocrinology},
  year = {2023},
  doi = {10.1210/endocr/bqad041}
}
Kostenlos starten →